Flibanserin Risk Management Challenges: Can A REMS Prevent Alcohol Interactions?
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA seeks advisory committee views on risk of hypotension and syncope with Sprout’s sexual dysfunction drug flibanserin when used alone or in combination with alcohol, and whether these risks outweigh ‘numerically small’ benefits over placebo.